Results 241 to 250 of about 122,871 (313)

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

BJU International, EarlyView.
Kevin G. Keane, Richard Gauci, Roslyn J. Francis, Andrew M. Scott, Cynthia Hawks, Andrisha‐Jade Inderjeeth, Ian D. Davis, Jayne Lim, Andrew Redfern, Dickon Hayne   +9 more
wiley   +1 more source

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production

Immunology &Cell Biology, EarlyView.
Sustained IL‐2 production delays T follicular helper cell differentiation and germinal center formation but does not alter final antibody titers or antigen‐specific humoral immunity after vaccination. Created in BioRender. Burton, A. (2026) https://BioRender.com/paggz41 Abstract Vaccines stimulate protective humoral immunity by coordinating lymphocyte ...
Silvia Innocentin, Ross McKenzie, Jayalini Assalaarachchi, Helena A Carslaw, Anusha Gupta, Sanne Cole, Adrian Liston, Michelle A Linterman, Louise Webb, Alice R Burton   +9 more
wiley   +1 more source

A multiplex TaqMan real-time PCR assay for differential identification of wild-type and vaccine strains of Mycoplasma gallisepticum. [PDF]

Poult Sci
Xin J, Zhang J, Liang S, Bi J, Wu J, Wei Z, Yang R, Zhao Z, Huang J, Li W, Yang M, Xue H, Huang H, Mu J, Ding J, Lei L, Zheng M.   +16 more
europepmc   +1 more source

Age‐related differences in mRNA vaccine immunogenicity and adjuvancy

Immunology &Cell Biology, EarlyView.
Older people often respond poorly to mRNA vaccines, with reduced T and B cell responses, but they also bear more morbidity and mortality for infectious diseases. This paper maps age‐related changes in mechanisms of adjuvancy that can shape the immunogenicity of mRNA vaccine in a mouse model. Created in BioRender.
Shivali Savita Chinni, Gemma S Trollope, Patrick Leung, Jonathan L McQualter, Chee Wah Tan, Linfa Wang, Leonard Lim, Adam K Wheatley, Jennifer A Juno, Stephen J Kent, Hareth A Al‐Wassiti, Colin W Pouton, Kylie M Quinn   +12 more
wiley   +1 more source

Next-Generation Vaccines for Co-Circulating PEDV and TGEV: Integrating Nucleic Acid Platforms, Mucosal Delivery, and AI-Driven Antigen Design. [PDF]

Transbound Emerg Dis
Hu X, Wang Z, Wang S, Sun H, Feng N, Li E, Xia X, Hu G, Yan F, Li B.   +9 more
europepmc   +1 more source

Core Components of Effective Home Visiting Programmes and Parenting Interventions Delivered by Nurses and Midwives—A Scoping Review

Journal of Advanced Nursing, EarlyView.
ABSTRACT Aim To investigate international evidence on home visits and parenting interventions delivered by nurses and midwives and to identify core components, such as intervention content, programme characteristics, contextual factors and implementation elements shared by effective interventions. Design Scoping Review.
Outi Savolainen, Hanna Rouvinen, Margaret M. Barry   +2 more
wiley   +1 more source

The Yellow Fever Vaccine Journey: Milestones and Future Directions. [PDF]

Vaccines (Basel)
Srivastava S, Jayaswal N, Gupta P, Sridhar SB, Jaiswal P, Tariq M, Rao GSNK, Mohanty A, Sah S, Mehta R, Hernández-Ovalle JP, Acosta-España JD, Zambrano L, Rodriguez-Morales AJ.   +13 more
europepmc   +1 more source

‘I Don't Want Another Five Years of “The Only Thing We Talk About Is Brexit”’: The Dynamics of EU (De)politicisation in Post‐Brexit Britain

JCMS: Journal of Common Market Studies, EarlyView.
Abstract The 2016 Brexit referendum was a watershed moment for the politicisation of the European Union (EU) in the United Kingdom. Much has been written about the politicising effects of the referendum, along with the Leave result's subsequent contestation in the media as well as in national and European election cycles.
Anne‐Marie Houde, Louis Stockwell
wiley   +1 more source